Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Labopat is a premier diagnostic laboratory based in Puebla, Mexico, specializing in high-complexity surgical pathology and molecular diagnostics. The company provides advanced testing services, including immunohistochemistry, next-generation sequencing (NGS), and fluorescence in situ hybridization (FISH), to support precision oncology and personalized medicine. Labopat serves as a critical partner for healthcare providers and the pharmaceutical industry, offering diagnostic validation for clinical trials and companion diagnostics. Accredited by the College of American Pathologists (CAP), the laboratory maintains international quality standards in its diagnostic processes. Its comprehensive portfolio covers a wide range of oncological indications, helping clinicians tailor treatments based on specific genetic and molecular profiles.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on LABOPAT.